Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

CUSIP: 702712100

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
3,182,163
Total 13F shares
43,736,986
Share change
-1,498,133
Total reported value
$277,681,358
Put/Call ratio
76%
Price per share
$6.35
Number of holders
94
Value change
-$20,365,609
Number of buys
54
Number of sells
40

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
13F
Company
219%
6,962,899
$69,350,000 30 Sep 2021
13F
FMR LLC
13F
Company
177%
5,632,556
$56,101,000 30 Sep 2021
13F
FRAZIER MANAGEMENT LLC
13F
Company
157%
5,009,219
$49,892,000 30 Sep 2021
13F
Versant Venture Management, LLC
13F
Company
156%
4,959,769
$49,399,000 30 Sep 2021
13F
BlackRock Finance, Inc.
13F
Company
98%
3,118,023
$31,057,000 30 Sep 2021
13F
New Leaf Venture Partners, L.L.C.
13F
Company
78%
2,497,922
$24,879,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
62%
1,983,044
$19,751,000 30 Sep 2021
13F
Boxer Capital, LLC
13F
Company
61%
1,928,315
$19,206,000 30 Sep 2021
13F
HIGHLINE CAPITAL MANAGEMENT, L.P.
13F
Company
37%
1,185,869
$11,811,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
36%
1,143,403
$11,389,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
25%
784,597
$7,815,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
21%
682,627
$6,799,000 30 Sep 2021
13F
Vivo Capital, LLC
13F
Company
17%
539,263
$5,371,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
15%
473,328
$4,714,000 30 Sep 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13%
421,178
$4,195,000 30 Sep 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
11%
344,178
$3,428,000 30 Sep 2021
13F
Weiss Multi-Strategy Advisers LLC
13F
Company
11%
336,034
$3,347,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
10%
327,969
$3,267,000 30 Sep 2021
13F
Woodline Partners LP
13F
Company
10%
321,791
$3,205,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
9.8%
313,008
$3,117,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
7.9%
250,713
$2,498,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
6.8%
217,682
$2,168,000 30 Sep 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
6.5%
205,640
$2,048,000 30 Sep 2021
13F
NORGES BANK
13F
Company
5.8%
184,400
$1,837,000 30 Sep 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
5%
158,500
$1,579,000 30 Sep 2021
13F
EMERALD ADVISERS, LLC
13F
Company
4.4%
140,699
$1,401,000 30 Sep 2021
13F
Alyeska Investment Group, L.P.
13F
Company
4.4%
138,807
$1,383,000 30 Sep 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
4.2%
133,200
$1,327,000 30 Sep 2021
13F
Logos Global Management LP
13F
Company
3.9%
125,010
$1,245,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
3.8%
120,270
$1,198,000 30 Sep 2021
13F
BAKER BROS. ADVISORS LP
13F
Company
3.7%
117,161
$1,167,000 30 Sep 2021
13F
HRT FINANCIAL LP
13F
Company
2.5%
80,513
$801,000 30 Sep 2021
13F
MARSHALL WACE, LLP
13F
Company
2.2%
70,923
$705,000 30 Sep 2021
13F
Ikarian Capital, LLC
13F
Company
2.1%
67,849
$677,000 30 Sep 2021
13F
Marshall Wace North America L.P.
13F
Company
2%
62,586
$624,000 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
1.8%
58,199
$580,000 30 Sep 2021
13F
CITIGROUP INC
13F
Company
1.7%
55,101
$549,000 30 Sep 2021
13F
Swiss National Bank
13F
Company
1.7%
53,700
$535,000 30 Sep 2021
13F
Trexquant Investment LP
13F
Company
1.6%
51,474
$513,000 30 Sep 2021
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
1.5%
48,000
$478,000 30 Sep 2021
13F
RHUMBLINE ADVISERS
13F
Company
1.5%
47,096
$469,000 30 Sep 2021
13F
CITADEL ADVISORS LLC
13F
Company
1.5%
46,508
$463,000 30 Sep 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
1.3%
39,810
$397,000 30 Sep 2021
13F
SG Americas Securities, LLC
13F
Company
1.2%
36,828
$367,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.1%
34,092
$340,000 30 Sep 2021
13F
Jill M. Quigley
3/4/5
Chief Operating Officer
mixed-class rows
399,988
mixed-class rows
$338,849 08 Dec 2021
Jump Financial, LLC
13F
Company
1%
32,700
$326,000 30 Sep 2021
13F
Vontobel Holding Ltd.
13F
Company
0.94%
30,000
$299,000 30 Sep 2021
13F
ExodusPoint Capital Management, LP
13F
Company
0.89%
28,408
$283,000 30 Sep 2021
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.81%
25,785
$257,000 30 Sep 2021
13F

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q4 2021

As of 31 Dec 2021, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,736,986 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, Versant Venture Management, LLC, BlackRock Inc., Deep Track Capital, LP, New Leaf Venture Partners, L.L.C., VANGUARD GROUP INC, Woodline Partners LP, FMR LLC, and MORGAN STANLEY. This page lists 94 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
98
Q4 2021 holders
94
Holder diff
-4
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.